Back to Medicine Index

Lanso 30 mg

Capsule

Generic: Lansoprazole

Square Pharmaceuticals PLC.

Therapeutic Class: Proton Pump Inhibitor

Indications

Duodenal and benign gastric ulcer, reflux oesophagitis and gastro-oesophageal reflux disease, acid-related dyspepsia, treatment and prevention of NSAID-associated ulcer, Zollinger-Ellison syndrome, and eradication of Helicobacter pylori in combination with antibiotics.

Pharmacology

Lansoprazole is a substituted benzimidazole that suppresses gastric acid secretion by inhibiting the hydrogen-potassium ATPase enzyme (the proton pump) of the gastric parietal cell.

Dosage & Administration

Adult: 30 mg once daily in the morning before food; duodenal ulcer for 4 weeks, gastric ulcer for 8 weeks, reflux oesophagitis for 4 to 8 weeks. Maintenance and acid-related dyspepsia: 15 to 30 mg once daily. H. pylori eradication: 30 mg twice daily with antibiotics for 7 to 14 days. Zollinger-Ellison syndrome: initially 60 mg once daily, adjusted according to response.

Side Effects

Headache, dizziness, diarrhoea, constipation, abdominal pain, nausea, flatulence, dry mouth, skin rash and tiredness.

Precautions & Warnings

Swallow the capsule whole; do not chew or crush the granules. Exclude gastric malignancy before treatment when alarm symptoms are present. Use with caution in liver impairment. Long-term use may lower magnesium and vitamin B12 levels and increase the risk of bone fracture. Use in pregnancy and breast-feeding only if advised by the physician.

Contraindications

Hypersensitivity to lansoprazole or other proton pump inhibitors.

Storage Conditions

Store below 30°C in a cool, dry place, away from light. Keep out of the reach of children.

This information is for reference only. Always consult a qualified doctor or pharmacist before taking any medicine.